Barely Significant
← all excerpts

The Use of Recombinant Bone Morphogenetic Protein-2 in the Treatment of Spondylodiscitis.

Global Spine J · 2026 · PMC12568556 · PMID 41151052

Europe PMCDOI
1
hedged sentence
0.0950
closest p · 1.9× alpha
0.0950
boldest claim

The sentences

did not reach statistical significanceP = 0.095so close (0.05 < p ≤ 0.1)
Although the fusion rate was higher in the BMP_Anterior/Posterior group, the difference did not reach statistical significance (96% vs 86%, P = 0.095) ( Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.